Skip to content
Advertisement

This Thursday, April 23, 2020, file screen grab taken from video issued by Britain's Oxford University shows a person being injected as part of the first human trials in the U.K. to test a potential coronavirus vaccine, untaken by Oxford University in England. AstraZeneca says late-stage trials of its COVID-19 vaccine were “highly effective’’ in preventing disease. A vaccine developed by AstraZeneca and the University of Oxford prevented 70% of people from developing the coronavirus in late-stage trials, the team reported Monday, Nov. 23, 2020. (Oxford University Pool via AP, File)

This Thursday, April 23, 2020, file screen grab taken from video issued by Britain's Oxford University shows a person being injected as part of the first human trials in the U.K. to test a potential coronavirus vaccine, untaken by Oxford University in England. AstraZeneca says late-stage trials of its COVID-19 vaccine were “highly effective’’ in preventing disease. A vaccine developed by AstraZeneca and the University of Oxford prevented 70% of people from developing the coronavirus in late-stage trials, the team reported Monday, Nov. 23, 2020. (Oxford University Pool via AP, File)

Featured Photo Galleries